98%
921
2 minutes
20
Objective: Identification of risk factors for depressive chronicity may reduce disease burden by informing prevention and treatment strategies. We aimed to estimate the prevalence of depression chronicity and explore factors linked to chronic depression in a longitudinal cohort.
Methods: Participants from the Canadian Longitudinal Study on Aging Comprehensive cohort who were depressed at baseline, based on a score of 10 or more on the Center for Epidemiologic Studies Depression-10 item scale (CESD-10), were included (n = 3473). Participants were considered to have chronic depression if they maintained a CESD-10 score of 10 or greater at the follow-up. Latent profile analyses (LPA) were used to determine baseline depression subtypes, baseline allostatic load biomarker (AL) profiles, and adverse childhood experience (ACE) profiles. Logistic regression was used to explore factors associated with chronic depression RESULTS: Depression was chronic for 46.6 % of the sample. Significant baseline predictors included depression subtype, with atypical and melancholic subtypes having 1.35 (95 %CI: 1.05-1.73) and 1.87 (95 %CI: 1.53-2.3) times greater odds, respectively, compared with the positive affect subtype. Greater odds of chronic depression were associated with moderate (OR 1.44, 95 %CI: 1.21-1.72) and physical ACE profiles (OR 1.47, 95 %CI: 1.16, 1.84), and with high-cardiovascular AL profile (OR 1.07, 95 %CI: 1.07-1.69), compared with low ACE and average AL profiles. Other significant baseline risk factors included lower annual household income, increased chronic conditions, lower perceived social status, and smoking.
Conclusions: Depression subtypes and stressor profiles were differentially associated with depression chronicity. The research may shed light on intervention and prevention in clinical practice.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jad.2025.120079 | DOI Listing |
Encephale
September 2025
Centre de référence régional des pathologies anxieuses et de la dépression, pôle de psychiatrie générale et universitaire, centre hospitalier Charles-Perrens, 33076 Bordeaux, France; Inserm U1215, Neurocentre Magendie, 33000 Bordeaux, France. Electronic address:
Neuropathic pain results from an injury or a dysfunction of the somatosensory system. Management of this disease is complex due to a restricted therapeutic arsenal and limited efficacy of currently available treatments. Because of its chronic and disabling nature, neuropathic pain is strongly associated with depressive disorders.
View Article and Find Full Text PDFMethods Cell Biol
September 2025
Histology and Cell Biology Department, School of Medicine, Complutense University of Madrid, Madrid, Spain. Electronic address:
Parkinson disease (PD) is the second most prevalent neurodegenerative disorder globally, trailing only Alzheimer´s disease. It currently affects nearly 3 % of individuals aged 65 and above. The disease is characterized by the progressive loss of dopaminergic neurons accompanied by a chronic neuroinflammatory process, which is responsible for both motor symptoms (tremor, rigidity, bradykinesia) and non-motor symptoms (depression, dysphagia, anxiety, constipation, and anosmia).
View Article and Find Full Text PDFAm J Clin Nutr
September 2025
Department of Geriatrics, The First Affiliated Hospital, Zhejiang University, School of Medicine, Hangzhou 3100003, China. Electronic address:
Background: Muscle quality index (MQI), a new metric for assessing sarcopenia, reflects the functional capacity of muscle. However, the associations between MQI and adverse health outcomes and the corresponding mechanisms are not well understood.
Objective: We aimed to prospectively evaluate the associations of MQI with risk of nine adverse health outcomes (ie, osteoarthritis, cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), respiratory disease, chronic kidney disease (CKD), liver disease, dementia, depression, and all-cause mortality), as well as the mediating role of metabolomics in these associations.
Brain Behav Immun
September 2025
Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology (BIST), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Biomedical Research Networking Center for Rare Diseases (CIBERER), Barcelona 08003, Spain.
Treatment-resistant depression (TRD) is a severe condition characterized by chronic and recurrent depressive symptoms, leading to significant morbidity and a considerable socio-economic impact. Genetic and biological studies suggest that TRD is associated with distinct biological characteristics. In this study, we analysed whole-transcriptome differences in 293 patients with major depressive disorder (MDD) to compare TRD (N = 150) vs non-TRD (N = 143) cases.
View Article and Find Full Text PDFJ Affect Disord
September 2025
Robert-Koch Institute, Department of Epidemiology and Health Monitoring, Berlin, Germany.
Background: Depressive symptoms significantly increase physical morbidity, mortality, and healthcare demands, while chronic diseases can exacerbate depressive symptoms. This study aimed to: 1) determine the prevalence of depressive symptoms among individuals with and without chronic diseases; 2) compare the number of chronic diseases across age groups in those with and without depressive symptoms; and 3) analyze associations between depressive symptoms and chronic diseases, adjusting for sociodemographic, socioeconomic, lifestyle, and health-related variables.
Methods: In this cross-sectional study, data from 275,009 participants (126,642 men, 148,367 women) in the third wave of the European Health Interview Survey (2018-2020) across 30 European countries were analyzed.